Practical molecular pathologic diagnosis of infiltrating gliomas

Surgical Pathology Clinics
Melike Pekmezci, Arie Perry

Abstract

Recent advances in molecular diagnostics have led to better understanding of glioma tumorigenesis and biology. Numerous glioma biomarkers with diagnostic, prognostic, and predictive value have been identified. Although some of these markers are already part of the routine clinical management of glioma patients, data regarding others are limited and difficult to apply routinely. In addition, multiple methods for molecular subclassification have been proposed either together with or as an alternative to the current morphologic classification and grading scheme. This article reviews the literature regarding glioma biomarkers and offers a few practical suggestions.

References

Oct 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·A J WongB Vogelstein
Aug 2, 1994·Proceedings of the National Academy of Sciences of the United States of America·R NishikawaH J Huang
Oct 1, 1996·Journal of Neuropathology and Experimental Neurology·Y OnoD N Louis
Apr 1, 1997·Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B·L S RaoE W Newcomb
Oct 17, 1998·Journal of the National Cancer Institute·J G CairncrossD N Louis
Aug 9, 2002·International Journal of Oncology·Xing FanJavier S Castresana
Oct 12, 2002·American Journal of Clinical Pathology·Richard A PraysonGene H Barnett
Nov 29, 2002·Frontiers in Bioscience : a Journal and Virtual Library·Arie PerryBernd W Scheithauer
Aug 9, 2003·Acta Neuropathologica·Nathalie BaezaHiroko Ohgaki
Sep 10, 2003·Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B·M A IdoateF J Pardo-Mindán
Dec 9, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Andrey KorshunovAndrey Golanov
Mar 2, 2005·Acta Neuropathologica·Portia A KreigerJeffrey A Golden
Apr 16, 2005·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Andrey KorshunovAndrey Golanov
Jun 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·UNKNOWN Intergroup Radiation Therapy Oncology Group Trial 9402Walter Curran
Apr 17, 2007·Neuro-oncology·Lauren E AbreyUNKNOWN Oligodendroglioma Study Group
Apr 3, 2008·Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B·Ingeborg FischerKenneth Aldape
Sep 6, 2008·Science·D Williams ParsonsKenneth W Kinzler
Jan 15, 2009·American Journal of Clinical Pathology·Yolanda RuanoBárbara Meléndez
Feb 11, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Martin J van den BentThierry Gorlia
Feb 21, 2009·The New England Journal of Medicine·Hai YanDarell D Bigner
Feb 28, 2009·The American Journal of Pathology·Takuya WatanabeHiroko Ohgaki
Jun 16, 2009·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Timo GaiserAndreas von Deimling
Sep 10, 2009·Cancer Science·Hiroko Ohgaki, Paul Kleihues
Nov 11, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Wolfgang WickMichael Weller
Nov 12, 2009·Brain Pathology·David CapperAndreas von Deimling
Feb 18, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Martin J van den BentMarc Sanson
Apr 30, 2010·Neurology·M LabussièreM Sanson
Jun 2, 2010·Journal of the National Cancer Institute·Zachary J Reitman, Hai Yan
Aug 18, 2010·Acta Neuropathologica·Markus J RiemenschneiderGuido Reifenberger
Oct 6, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John H SampsonDarell D Bigner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Related Papers

Seminars in Radiation Oncology
Melike Pekmezci, Arie Perry
Soins; la revue de référence infirmière
Alexandra Benouaich-Amiel
Neurologic Clinics
Mark R Gilbert, Frederick F Lang
Zhonghua wai ke za zhi [Chinese journal of surgery]
Hai-hui JiangSong Lin
© 2021 Meta ULC. All rights reserved